2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
US-10093671-B2 · Oct 9, 2018 · US
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 55310820 |
| Family type | — |
| Earliest priority | Feb 11, 2015 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US10093671B2 — 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection |
Best representative member for this family based on priority and filing country.
US10093671B2 — 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection (published Oct 9, 2018)
Related publications in this family.
US-10093671-B2 · Oct 9, 2018 · US
US-2017342069-A1 · Nov 30, 2017 · US